INTERPACE BIOSCIENCES, INC. (IDXG)
Data as of , from SEC Form 4 filings.
See up to 3 months of IDXG. The 7-day demo opens the 1M and 3M ranges and puts IDXG on your watchlist.
Start 7-day demoLatest IDXG insider trades
About INTERPACE BIOSCIENCES, INC. (IDXG)
IDXG Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 8 | 3,628,816 | |
| Option exercise | 4 | 4,487,544 | |
| Tax withholding / forfeiture | 1 | 581,718 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IDXG insider transactions (Form 4)
2711 Form 4 filings on record, the earliest from Oct 15, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Thomas W. Burnell - Officer | Option exercise | Common Stock | 1,966,763 footnote F1 | $0.00 | - | |
| Thomas W. Burnell - Officer | Tax withholding / forfeiture | Common Stock | 581,718 footnote F2 | $8.05 | $937K | |
| Thomas W. Burnell - Officer | Grant or award | Restricted Stock Units | 1,966,763 | $0.00 | - | |
| Thomas W. Burnell - Officer | Option exercise | Restricted Stock Units | 1,966,763 | $0.00 | - | |
| Thomas W. Burnell - Officer | Grant or award | Stock Option (right to buy) | 554,018 | $0.00 | - | |
| ||||||
| Vijay Aggarwal - Director | Grant or award | Restricted Stock Units | 69,252 | $0.00 | - | |
| Fortunato R. Rocca - Director | Grant or award | Restricted Stock Units | 69,252 | $0.00 | - | |
| Joseph D. Keegan - Director | Grant or award | Restricted Stock Units | 69,252 | $0.00 | - | |
| Stephen J. Sullivan - Director | Grant or award | Restricted Stock Units | 69,252 | $0.00 | - | |
| Christopher McCarthy - Officer | Option exercise | Common Stock | 277,009 footnote F1 | $0.00 | - | |
| Christopher McCarthy - Officer | Grant or award | Restricted Stock Units | 554,018 | $0.00 | - | |
| Christopher McCarthy - Officer | Option exercise | Restricted Stock Units | 277,009 | $0.00 | - | |
| Christopher McCarthy - Officer | Grant or award | Stock Option (right to buy) | 277,009 | $0.00 | - | |
| ||||||
| 1315 Capital II, L.P. - 10% Owner | Other | Common Stock | 9,405,941 | $2.02 footnote F2 | $19.00M | |
| 1315 Capital II, L.P. - 10% Owner | Other | Series C Convertible Preferred Stock | 19,000 | $0.00 | - | |
| ||||||
| Ampersand 2018 Limited Partnership - 10% Owner | Other | Common Stock | 13,861,386 | $2.02 footnote F2 | $28.00M | |
| Ampersand 2018 Limited Partnership - 10% Owner | Other | Series C Convertible Preferred Stock | 28,000 | $0.00 | - | |
| ||||||
| Christopher McCarthy - Officer | Option exercise | Common Stock | 7,556 | $0.00 | - | |
| Christopher McCarthy - Officer | Option exercise | Common Stock | 1,095 | $0.00 | - | |
| Christopher McCarthy - Officer | Option exercise | Common Stock | 7,556 | $0.00 | - | |
| Christopher McCarthy - Officer | Option exercise | Common Stock | 6,045 | $0.00 | - | |
| Christopher McCarthy - Officer | Option exercise | Common Stock | 15,112 | $0.00 | - | |
| Christopher McCarthy - Officer | Option exercise | Common Stock | 1,111 | $0.00 | - | |
| 1315 Capital II, L.P. - 10% Owner | Derivative | Series B Convertible Preferred Stock | 19,000 | - | - | |
| 1315 Capital II, L.P. - 10% Owner | Grant or award | Series C Convertible Preferred Stock | 19,000 | - | - | |
| Ampersand 2018 Limited Partnership - 10% Owner | Derivative | Series B Convertible Preferred Stock | 28,000 | - | - | |
| Ampersand 2018 Limited Partnership - 10% Owner | Grant or award | Series C Convertible Preferred Stock | 28,000 | - | - | |
Item 5.03, 7.01, 9.01
Item 5.02, 9.01
Item 5.07
Item 2.02, 9.01
IDXG insider trading FAQ
What is the latest insider trade for IDXG?
INTERPACE BIOSCIENCES, INC. (IDXG) had 6 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for IDXG runs to 11 Form 4 filings, the earliest from 2024-10-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IDXG stock?
No insider purchases of IDXG were filed in the last 90 days.
How many insiders are selling IDXG stock?
No insider sales of IDXG were filed in the last 90 days.
Where can I see IDXG SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IDXG Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Thomas W. Burnell view on EDGAR
- - Vijay Aggarwal view on EDGAR
- - Fortunato R. Rocca view on EDGAR
- - Joseph D. Keegan view on EDGAR
- - Stephen J. Sullivan view on EDGAR
- - Christopher McCarthy view on EDGAR
- - 1315 Capital II, L.P. view on EDGAR
- - Ampersand 2018 Limited Partnership view on EDGAR
- - Christopher McCarthy view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where IDXG's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IDXG with a 7-day demo
- IDXG on your watchlist
- Every IDXG Form 4 filing on record
- Up to 3 months of IDXG price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
